Aim and Scope - Journal of Pharmacokinetics and Experimental Therapeutics

Journal of Pharmacokinetics & Experimental Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Aim and Scope

Journal of pharmacokinetics & experimental therapeutics is an open access journal that focuses on pharmacokinetic properties of drugs, including absorption, distribution, metabolism and excretion (ADME) while underlining the importance of experimental therapeutics in pharmacokinetic research, adalimumab pharmacokinetics, ADME studies, atorvastatin pharmacokinetics , clinical pharmacokinetics, clopidogrel pharmacokinetics, dmpk studies, esomeprazole pharmacokinetics, etanercept pharmacokinetics, fluticasone pharmacokinetics, infliximab pharmacokinetics, linear pharmacokinetics, morphine pharmacokinetics, nonlinear pharmacokinetics, olanzapine pharmacokinetics, pharmacokinetics modelling, quetiapine pharmacokinetics, rosuvastatin pharmacokinetics.